AHR and cancer: In addition, we recently identified the L-amino acid oxidase interleukin-4-induced-1 (IL4I1) as a novel and very potent upstream regulator of AHR, and we showed that IL4I1 associates more frequently with AHR activity than IDO1 or TDO2 in cancer [35].